ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing
Go back to ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing| Abbott Laboratories (NYSE: ABT) | Delayed: 100.89 +0.32 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.57 | 52 Week High | $46.38 | |||
| Open | $101.23 | 52 Week Low | $36.00 | |||
| Day High | $101.90 | P/E | 67.26 | |||
| Day Low | $100.07 | EPS | $1.50 | |||
| Volume | 1,482,019 | |||||
